Soulaire marketed its external counterpulsation system to grow new arteries, repair organ dysfunction and treat COVID-19, among other uses, without evidence.
FDA warns Soulaire to stop selling device outside authorized uses Read More »
As its lead oral targeted protein degrader moves through Phase III in partnership with Pfizer, Arvinas signs a licensing deal handing over all rights and responsibilities to Novartis.
Arvinas Strikes Deals With Pfizer, Novartis to Compete in Protein Degrader Space Read More »
After withdrawing ALS drug Relyvrio from the U.S. and Canadian markets and laying off 70% of its workforce, the Cambridge, Mass.–based biopharma got a much-needed win in Wolfram syndrome.
Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio? Read More »
Amylyx looks to the future after Relyvrio withdrawal, ADCs continue to attract investment and the drug shortage persists in the U.S.
Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages Read More »
¿Sabías que una negligencia médica puede tener consecuencias para el resto de tu vida? Denunciar puede prevenir futuros incidentes similares. ¿Qué es una Negligencia Médica? Una negligencia médica es una falla por …
¿Qué Hacer si Eres Víctima de una Negligencia Médica? Read More »
Orexo AB, announces that the United States Patent and Trademark Office has granted another US patent specifically related to OX640, Orexo’s nasal epinephrine powder product based on the AmorphOX® drug delivery platform.
Orexo extends patent protection for its nasal epinephrine powder product OX640 in the US Read More »
Evotec SE announced the appointment of Aurélie Dalbiez as the Company’s new Chief People Officer, effective 15 June 2024.
Evotec welcomes Aurélie Dalbiez as Chief People Officer Read More »
Novartis announced data from the ALITHIOS open-label extension study showing sustained efficacy of first-line, continuous Kesimpta® treatment for up to six years in recently diagnosed – defined as starting treatment within three years of initial diagnosis – treatment-naïve people living with relapsing multiple sclerosis.
Las intolerancias alimentarias son una preocupación creciente en la sociedad moderna, afectando a millones de personas en todo el mundo. Desde la intolerancia al gluten hasta la intolerancia a la lactosa, estas condiciones pueden tener un impacto significativo en la calidad de vida de quienes …
Sir Charles Algernon Parsons fue un visionario cuyos logros en la ingeniería y la tecnología moldearon el mundo moderno de formas inimaginables. Desde revolucionar la navegación marítima hasta sentar las bases para la generación de energía eléctrica a …
Sir Charles Algernon Parsons: Pionero de la ingeniería y la tecnología Read More »
